Search results for "FIBRILLATION"

showing 10 items of 509 documents

Efecto del estiramiento miocárdico sobre las frecuencias de activación determinadas mediante análisis espectral durante la fibrilación ventricular

2002

Introduction and objectives. The aim of this study was to analyze the effects of myocardial stretching on excitation frequencies, as determined by spectral analysis, during ventricular fibrillation. Methods. In 12 isolated rabbit heart preparations, ventricular activation during ventricular fibrillation was recorded with multiple electrodes. Recordings were obtained before, during and after ventricular dilatation produced with an intraventricular balloon. The dominant frequency of the signals obtained with each of the electrodes was determined by spectral analysis. Results. During the control phase, the mean, minimum and maximum dominant frequencies were, respectively, 14.3 ± 1.7, 12.5 ± 1.…

medicine.medical_specialtyExperimental modelbusiness.industryRabbit heartVentricular dilatationDominant frequencymedicine.diseaseSurgeryVentricular activationmedicine.anatomical_structureNuclear magnetic resonanceVentricleVentricular fibrillationmedicineCardiology and Cardiovascular MedicinebusinessLateral wallRevista Española de Cardiología
researchProduct

Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020

2020

The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: Epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; Cardiovascular (CV) risk tables and recommendations for the calculation of CV risk; Main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; Indications for antiplatelet therapy, a…

medicine.medical_specialtyFamily medicineMedicina:Health Care::Environment and Public Health::Public Health::Epidemiologic Factors::Causality::Risk Factors [Medical Subject Headings]030204 cardiovascular system & hematologyPharmacological treatment:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension [Medical Subject Headings]03 medical and health sciences0302 clinical medicineDiabetes mellitusDiabetes mellitusEpidemiologymedicine030212 general & internal medicineIntensive care medicine:Diseases::Cardiovascular Diseases [Medical Subject Headings]lcsh:R5-920:Diseases::Endocrine System Diseases::Diabetes Mellitus [Medical Subject Headings]business.industryMedicina de familia:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology Social::Life Style [Medical Subject Headings]Atrial fibrillationGeneral MedicineAtención primariamedicine.diseasePrimary careCardiovasculardiseasesHealth promotionCardiovascular diseases:Health Care::Health Care Facilities Manpower and Services::Health Promotion [Medical Subject Headings]Preventive activitiesEnfermedades cardiovasculareslcsh:Medicine (General)Family PracticebusinessDyslipidemia
researchProduct

The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS

2008

Atrial fibrillation (AF) is the most common rhythm disturbance in medical practice and represents a very expensive health problem. AF can be managed with the prevention of thromboembolism and either a rate control of rhythm strategy. As both strategies have important limitations, probably a preventative strategy in patients at risk of developing arrhythmia can be a more attractive option. The renin-angiotensin system (RAS) seems to be involved in the genesis of arrhythmia by the following two mechanisms: 1. the induction of atrial fibrosis and structural remodelling by mitogen-activated protein kinase (MAPK) expression and reduction of collagenase activity; 2. the induction of electrical re…

medicine.medical_specialtyHeart diseaseGenotypeElectric CountershockAngiotensin-Converting Enzyme InhibitorsReview ArticleRenin-Angiotensin Systemrenin-angiotensin system atrial fibrillation ACE-I ARBDiabetes mellitusInternal medicineRenin–angiotensin systemAtrial FibrillationmedicineHumansPharmacology (medical)PharmacologyMitogen-Activated Protein Kinase KinasesEvidence-Based Medicinebiologybusiness.industryAngiotensin IIfungifood and beveragesAtrial fibrillationAngiotensin-converting enzymemedicine.diseaseAngiotensin IIEndocrinologyHeart failureACE inhibitorCardiologybiology.proteinbusinessAnti-Arrhythmia Agentsmedicine.drug
researchProduct

Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.

2021

With increasing life-expectancy and changing demographics, non-valvular atrial fibrillation (AF) is currently the most common indication for long-term oral anticoagulation (OAC) in low and middle income countries (LMICs). Due to a decreasing trend in the prevalence of rheumatic heart disease (RHD), valve disease as a primary cause of AF now constitutes a small fraction of all people with AF. Moreover, emerging data also indicate that, patients with significant valve disease and AF may have a risk of stroke similar to, if not lower than, those with non-valvular AF. Previous trials of anticoagulation for AF excluded people from LMICs partly because valvular AF constituted a large proportion o…

medicine.medical_specialtyHeart diseaseRD1-811medicine.drug_classMEDLINEAdministration Oral030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineThromboembolismAtrial FibrillationOpinion PapermedicineDiseases of the circulatory (Cardiovascular) systemHumans030212 general & internal medicineMedical prescriptionIntensive care medicineStrokeDeveloping Countriesbusiness.industryvalvular heart diseaseAnticoagulantsAtrial fibrillationVitamin K antagonistmedicine.diseaseClinical trialStrokeRC666-701SurgeryCardiology and Cardiovascular MedicinebusinessIndian heart journal
researchProduct

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

2008

Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontains surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, …

medicine.medical_specialtyHeart diseasemedicine.medical_treatmentAdrenergic beta-AntagonistsElectric CountershockPHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.Catheter ablationElectrocardiographyPharmacotherapyInternal medicineAtrial FibrillationDrug DiscoverymedicineHumanscardiovascular diseasesChildUltrasonographyPharmacologyFibrillationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Cardiac Pacing ArtificialAtrial fibrillationCalcium Channel Blockersmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareAtrial fibrillation atrial flutter pharmacological therapy childrenAtrial FlutterChronic DiseaseCatheter Ablationcardiovascular systemCardiologymedicine.symptombusinessAnti-Arrhythmia AgentsElectrocardiographyAtrial flutterCurrent Pharmaceutical Design
researchProduct

Atrial fibrillation in high-risk patients with ischaemic stroke – Authors' reply

2017

medicine.medical_specialtyHigh risk patientsbusiness.industryMEDLINEAnticoagulantsAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseStroke03 medical and health sciences0302 clinical medicineText miningRisk FactorsInternal medicineAtrial FibrillationIschaemic strokeCardiologyHumansMedicineNeurology (clinical)businessStroke030217 neurology & neurosurgeryThe Lancet Neurology
researchProduct

Effect of the Alterations in Contractility and Morphology Produced by Atrial Fibrillation on the Thrombosis Potential of the Left Atrial Appendage

2021

Atrial fibrillation (AF) is a common arrhythmia mainly affecting the elderly population, which can lead to serious complications such as stroke, ischaemic attack and vascular dementia. These problems are caused by thrombi which mostly originate in the left atrial appendage (LAA), a small muscular sac protruding from left atrium. The abnormal heart rhythm associated with AF results in alterations in the heart muscle contractions and in some reshaping of the cardiac chambers. This study aims to verify if and how these physiological changes can establish hemodynamic conditions in the LAA promoting thrombus formation, by means of computational fluid dynamic (CFD) analyses. In particular, sinus …

medicine.medical_specialtyHistologythromboembolic eventleft atrial appendagelcsh:Biotechnology0206 medical engineeringBiomedical EngineeringThrombogenicityHemodynamicsBioengineering02 engineering and technology030204 cardiovascular system & hematologyContractilitySettore ING-IND/14 - Progettazione Meccanica E Costruzione Di Macchine03 medical and health sciencescomputational fluid dynamic0302 clinical medicinecardiac wall motionInternal medicinelcsh:TP248.13-248.65Medicineatrial fibrillationThrombusStrokeOriginal ResearchFibrillationbusiness.industrySettore ING-IND/34 - Bioingegneria IndustrialeBioengineering and BiotechnologyAtrial fibrillationmedicine.disease020601 biomedical engineeringThrombosisCardiologymedicine.symptombusinessBiotechnologyFrontiers in Bioengineering and Biotechnology
researchProduct

Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.

2017

Summary Background Atrial fibrillation is a major risk factor for recurrent ischaemic stroke, but often remains undiagnosed in patients who have had an acute ischaemic stroke. Enhanced and prolonged Holter-electrocardiogram-monitoring might increase detection of atrial fibrillation. We therefore investigated whether enhanced and prolonged rhythm monitoring was better for detection of atrial fibrillation than standard care procedures in patients with acute ischaemic stroke. Methods Find-AF randomised is an open-label randomised study done at four centres in Germany. We recruited patients with acute ischaemic stroke (symptoms for 7 days or less) aged 60 years or older presenting with sinus rh…

medicine.medical_specialtyIntention-to-treat analysisbusiness.industryAtrial fibrillation030204 cardiovascular system & hematologymedicine.disease3. Good healthlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineClinical endpointCardiologyMedicineSinus rhythmNeurology (clinical)cardiovascular diseasesRisk factorbusinessStroke030217 neurology & neurosurgeryAtrial flutterThe Lancet. Neurology
researchProduct

Functional Data Analysis for ECG Recordings of Paroxysmal Atrial Fibrillation Patients Before and After Pulmonary Vein Isolation

2018

Pulmonary vein isolation is the cornestone of current ablation techniques for patients with paroxysmal atrial fibrillation in order avoid recurrences of the arrhythmia and maintain sinus rhythm. This study aimed to analyse the existence of significant variations in surface ECG after pulmonary vein isolation by means of functional data analysis. 12 consecutive unselected patients suffering from paroxysmal atrial fibrillation who underwent catheter ablation were included in the study. Each patient was monitored in sinus rhythm before and after catheter ablation. P-waves of bipolar lead II were delineated. Functional data were fitted from these segments and the first and second derivatives eva…

medicine.medical_specialtyIsolation (health care)Paroxysmal atrial fibrillationbusiness.industrymedicine.medical_treatmentNon invasiveFunctional data analysisCatheter ablation030204 cardiovascular system & hematologyPulmonary vein03 medical and health sciences0302 clinical medicineInternal medicinemedicineCardiologySinus rhythm030212 general & internal medicinebusinessBipolar lead
researchProduct

Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials.

2021

Abstract Aims  The aim of this study was to systematically assess the effects of antiplatelets on clinical outcomes in patients with atrial fibrillation (AF), treated and not-treated with oral anticoagulation. Methods and results  We searched MEDLINE, Embase, and CENTRAL from inception until September 2020. From 5446 citations, we selected randomized trials allocating patients with AF to antiplatelet therapy vs. control. We applied random-effects models for meta-analysis and assessed potential effect modification with background anticoagulation use. Eighteen trials including 21 518 participants met our prespecified eligibility criteria. In 10 studies without background anticoagulation, anti…

medicine.medical_specialtyMEDLINEMyocardial InfarctionHemorrhage030204 cardiovascular system & hematologylaw.inventionBrain Ischemia03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineAtrial FibrillationMedicineHumansPharmacology (medical)030212 general & internal medicineMyocardial infarctionStrokeRandomized Controlled Trials as TopicAspirinbusiness.industryAnticoagulantsAtrial fibrillationmedicine.diseaseConfidence interval3. Good healthStrokeRelative riskCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugEuropean heart journal. Cardiovascular pharmacotherapy
researchProduct